Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3724 3785 3791 3796
This examiner grants 56% of resolved cases
Aurelie H Tu, an examiner in Art Unit 3724, has 241 resolved cases. The allowance rate is 56.4 percent. A high interview lift of 60.0 percent is reported, suggesting that interviews are highly impactful for this examiner. This 60.0 percent lift is a critical insight, as it indicates that an interview can significantly increase the probability of success. Practitioners should consider the 56.4 percent allowance rate as a baseline that can be improved through direct engagement in Tech Center 3700.
The median days to allowance is 1337. Given the 60.0 percent interview lift, practitioners should almost certainly schedule an interview to improve their chances. The long pendency of 1337 days highlights the importance of using every available tool to advance prosecution efficiently. With 241 resolved cases, the data shows a clear pattern where verbal communication is key. The 56.4 percent allowance rate provides a moderate chance of success, but the interview lift is the most important factor in this profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18102937 | WEARABLE ELECTRONIC DEVICE AND METHOD OF OPERATING THE SAME | Non-Final OA | SAMSUNG ELECTRONICS CO., LTD. |
| 18486030 | FUNCTIONAL THRESHOLD POWER PREDICTION USING MACHINE LEARNING | Final Rejection | Apple Inc. |
| 18298183 | Electronic Devices With Improved Aerobic Capacity Estimation | Final Rejection | Apple Inc. |
| 18347667 | PHRENIC NERVE INTEGRITY AND RAMPED-UP BURST | Final Rejection | Covidien LP |
| 18987601 | BRAIN WAVE DETECTION SYSTEM, BRAIN WAVE DETECTION METHOD AND NON-TRANSITORY STORAGE MEDIUM STORING NOISE REDUCTION PROCESSING PROGRAM | Non-Final OA | TOYOTA JIDOSHA KABUSHIKI KAISHA |
| 18811331 | ANALYSIS OF GLUCOSE MEDIAN, VARIABILITY, AND HYPOGLYCEMIA RISK FOR THERAPY GUIDANCE | Non-Final OA | Abbott Diabetes Care Inc. |
| 18009472 | ANALYTE SENSORS FEATURING ONE OR MORE DETECTION-FACILITATING ENHANCEMENTS | Final Rejection | Abbott Diabetes Care Inc. |
| 18682349 | METHOD AND SYSTEM FOR GENERATING RESPIRATION SIGNALS FOR USE IN ELECTROPHYSIOLOGY PROCEDURES | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 18267583 | VISUALIZING AND SIMULATING CHANGES IN OXYGENATION | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18703784 | GAIT MEASUREMENT DEVICE, MEASUREMENT DEVICE, GAIT MEASUREMENT SYSTEM, GAIT MEASUREMENT METHOD, AND RECORDING MEDIUM | Non-Final OA | NEC Corporation |
| 18678729 | APPARATUS AND METHOD FOR PRESENTING VISUAL STIMULUS BY USING AUGMENTED REALITY | Final Rejection | Kia Corporation |
| 17976970 | OCULAR IMPEDANCE-BASED SYSTEM FOR BRAIN HEALTH MONITORING | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18154045 | APPARATUS AND COMPUTER-IMPLEMENTED METHOD FOR PROVIDING INFORMATION ABOUT A USER'S BRAIN RESOURCES, NON-TRANSITORY MACHINE-READABLE MEDIUM AND PROGRAM | Non-Final OA | Sony Group Corporation |
| 18257473 | Calibration of Positions of EEG Electrodes on a Subject | Final Rejection | Telefonaktiebolaget LM Ericsson (publ) |
| 18691901 | MEASUREMENT DEVICE | Non-Final OA | Nippon Telegraph and Telephone Corporation |
| 18990328 | SYSTEM AND METHOD FOR SUBJECTIVE FLOATER ASSESSMENT | Non-Final OA | Alcon Inc. |
| 18223785 | SYSTEMS AND METHODS OF OPTICAL NEURAL STIMULATION FOR INTRAOPERATIVE NERVE MONITORING | Final Rejection | VANDERBILT UNIVERSITY |
| 18302730 | SYSTEMS FOR OPTIMIZING POWER CONSUMPTION OF A WEARABLE DEVICE USING SENSOR-BASED DETERMINATIONS OF POSITIONAL STATES OF A PORTION OF THE WEARABLE DEVICE, AND METHODS OF USE THEREOF | Final Rejection | Meta Platforms Technologies, LLC |
| 18485035 | DETERMINING OPERATIONAL CAPABILITY FOR HUMAN-OPERATED SYSTEMS AND CONTROL APPLICATIONS | Final Rejection | Nvidia Corporation |
| 17919474 | METHODS AND SYSTEMS FOR PREDICTING THE EFFECT OF INHALED AND INFUSED ANESTHETICS | Non-Final OA | Board of Trustees of the University of Arkansas |
| 18915186 | PRECONNECTED ANALYTE SENSORS | Non-Final OA | DexCom, Inc. |
| 18691642 | TWO COMPARTMENT FACE MASK | Non-Final OA | 3M Innovative Properties Company |
| 18020045 | NEUROMUSCULAR CHARACTERISATION METHOD AND ASSOCIATED MEASURING BENCH | Final Rejection | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 18088039 | SYSTEMS AND METHODS FOR DETERMINING CARDIAC OUTPUT | Final Rejection | The Brigham and Women's Hospital Inc. |
| 19044435 | VOICE-BASED METHOD AND SYSTEM FOR MANAGEMENT OF TYPE 2 DIABETES | Non-Final OA | UpDoc Inc. |
| 19044423 | VOICE-BASED METHOD AND SYSTEM FOR MANAGEMENT OF TYPE 2 DIABETES | Non-Final OA | UpDoc Inc. |
| 19024204 | SYSTEMS AND METHODS FOR ANALYSIS OF TEMPERATURE SIGNALS FROM AN ABREU BRAIN THERMAL TUNNEL AND TREATMENT OF HUMAN CONDITIONS VIA THE ABREU BRAIN THERMAL TUNNEL | Non-Final OA | Brain Tunnelgenix Technologies Corp. |
| 19000768 | SYSTEMS AND METHODS FOR ANALYSIS OF TEMPERATURE SIGNALS FROM AN ABREU BRAIN THERMAL TUNNEL AND TREATMENT OF HUMAN CONDITIONS VIA THE ABREU BRAIN THERMAL TUNNEL | Non-Final OA | Brain Tunnelgenix Technologies Corp. |
| 18894108 | SYSTEMS AND METHODS FOR ANALYSIS OF TEMPERATURE SIGNALS FROM AN ABREU BRAIN THERMAL TUNNEL AND TREATMENT OF HUMAN CONDITIONS VIA THE ABREU BRAIN THERMAL TUNNEL | Non-Final OA | Brain Tunnelgenix Technologies Corp. |
| 19018729 | APPARATUS, SYSTEM, AND METHOD FOR HEALTH AND MEDICAL SENSING | Non-Final OA | ResMed Sensor Technologies Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy